Alyeska Investment Group’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-39,827
Closed -$1.03M 518
2018
Q2
$1.03M Buy
39,827
+1,274
+3% +$32.9K 0.01% 366
2018
Q1
$921K Buy
+38,553
New +$921K 0.01% 361
2015
Q4
Sell
-98,380
Closed -$1.65M 483
2015
Q3
$1.65M Buy
98,380
+26,504
+37% +$444K 0.02% 340
2015
Q2
$1.89M Buy
71,876
+1,163
+2% +$30.5K 0.02% 335
2015
Q1
$1.24M Buy
70,713
+5,198
+8% +$90.9K 0.02% 392
2014
Q4
$1.14M Buy
65,515
+43,537
+198% +$756K 0.02% 370
2014
Q3
$409K Sell
21,978
-28,223
-56% -$525K 0.01% 343
2014
Q2
$918K Buy
+50,201
New +$918K 0.02% 319